Sale by Scott Tarriff of 9511 shares of Eagle Pharmaceuticals
| EGRXDelisted Stock | USD 1.99 0.02 1.02% |
Slightly above 50% of Eagle Pharmaceuticals' investors are presently thinking to get in. The analysis of overall sentiment of trading Eagle Pharmaceuticals pink sheet suggests that some investors are interested at this time. Eagle Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Eagle Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Eagle |
Filed transaction by Eagle Pharmaceuticals Inc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Eagle Pharmaceuticals Fundamental Analysis
We analyze Eagle Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eagle Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Eagle Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Eagle Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Eagle Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eagle Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eagle Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eagle Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Eagle Pharmaceuticals Related Equities
| ALKS | Alkermes Plc | 1.11 | ||||
| PAHC | Phibro Animal | 0.37 | ||||
| ANIP | ANI Pharmaceuticals | 0.35 | ||||
| COLL | Collegium Pharmaceutical | 0.28 | ||||
| AMPH | Amphastar | 0.14 | ||||
| PBH | Prestige Brand | 0.47 | ||||
| RGC | Regencell Bioscience | 0.53 | ||||
| EOLS | Evolus | 2.40 |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Eagle Pink Sheet
If you are still planning to invest in Eagle Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eagle Pharmaceuticals' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |